These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4336736)

  • 21. Treatment of mice with IL-12 DNA constructs leads to augmented NK activity in lungs but low IFN-gamma release -- implications for Bordetella pertussis infections following aerosol challenge.
    Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Rodgers A; Watanabe M; Xing D; Walker KB
    Cytokine; 2005 May; 30(3):100-8. PubMed ID: 15826816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bordetella pertussis infection attenuates clinical course of acute bronchiolitis.
    Abu Raya B; Bamberger E; Kassis I; Kugelman A; Srugo I; Miron D
    Pediatr Infect Dis J; 2013 Jun; 32(6):619-21. PubMed ID: 23429556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
    Alonso JM; Rocancourt M; Le Nin S; Brezin C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoradiographic studies on cell proliferation during splenomegaly induced by Bordetella pertussis in mice.
    Stöcker E; Finger H
    Virchows Arch B Cell Pathol; 1972; 10(3):179-83. PubMed ID: 4338202
    [No Abstract]   [Full Text] [Related]  

  • 25. An immunofluorescence study of the action of antibody in experimental intracerebral infection of mice with Bordetella pertussis.
    Iida T; Kusano N; Yamamoto A; Konosu M
    J Pathol Bacteriol; 1966 Oct; 92(2):359-67. PubMed ID: 4290146
    [No Abstract]   [Full Text] [Related]  

  • 26. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL
    Annu Rev Microbiol; 1986; 40():661-86. PubMed ID: 2877614
    [No Abstract]   [Full Text] [Related]  

  • 28. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
    Fennelly NK; Sisti F; Higgins SC; Ross PJ; van der Heide H; Mooi FR; Boyd A; Mills KH
    Infect Immun; 2008 Mar; 76(3):1257-66. PubMed ID: 18195025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the biological properties of the pertussis microbe exposed to antibiotics].
    Bakulina NA; Efimova OG; Samsonova VS; Bevz NI
    Antibiotiki; 1982 Nov; 27(11):844-50. PubMed ID: 6295258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET.
    Veal-Carr WL; Stibitz S
    Mol Microbiol; 2005 Feb; 55(3):788-98. PubMed ID: 15661004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A commentary on the pathogenesis of pertussis.
    Hewlett EL
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S94-8. PubMed ID: 10447025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes within the genus Bordetella influenced by phages.
    Mebel S; Lapaeva IA; Sinyashina LN; Rustenbach S; Murashko SN
    Dev Biol Stand; 1985; 61():281-8. PubMed ID: 2872115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of adhesin release for mucosal colonization by a bacterial pathogen.
    Coutte L; Alonso S; Reveneau N; Willery E; Quatannens B; Locht C; Jacob-Dubuisson F
    J Exp Med; 2003 Mar; 197(6):735-42. PubMed ID: 12629063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bordetella pertussis and mixed infections.
    Versteegh FG; Mooi-Kokenberg EA; Schellekens JF; Roord JJ
    Minerva Pediatr; 2006 Apr; 58(2):131-7. PubMed ID: 16835573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
    Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
    Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of subsequent intracerebral infection with Bordetella pertussis by previous local brain irradiation.
    Hopewell JW; Adams GA
    Exp Neurol; 1970 Jan; 26(1):173-82. PubMed ID: 4312350
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth idiosyncrasies of some Bordetella pertussis strains, and the intracerebral virulence of these strains in mice.
    BROWN AM
    J Gen Microbiol; 1959 Jun; 20(3):532-9. PubMed ID: 13664900
    [No Abstract]   [Full Text] [Related]  

  • 39. Some factors influencing the virulence for mice of Bordetella pertussis by the intracerebral route.
    STANDFAST AF
    Immunology; 1958 Apr; 1(2):123-34. PubMed ID: 13538529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The interrelation of the composition of the nutrient media with the growth and biological properties of Bordetella pertussis].
    Stepanshina VN; Alekseeva LN; Korobova OV; Logacheva LV; Shepelin AP; Anisimov GA; Volkovoĭ KI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):26-7. PubMed ID: 7879517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.